Search results
Why CymaBay, With 159% Growth This Year, Just Surged For A Second Day Running
Investor's Business Daily· 8 months agoShares of CBAY stock surged for a second day Friday as analysts compared CymaBay Therapeutics'...
Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates
Zacks via Yahoo Finance· 2 months agoIt has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...
Why CymaBay Therapeutics Stock Rocketed Nearly 8% Higher Today
Motley Fool· 6 months agoHardly for the first time this year, biotech CymaBay Therapeutics (NASDAQ: CBAY) had a winning day...
Why CymaBay Therapeutics Stock Triumphed Again on Tuesday
Motley Fool· 7 months agoThe hot-streak biotech stock of the moment, CymaBay Therapeutics (NASDAQ: CBAY), again rose in price...
Why CymaBay Therapeutics Stock Nose-Dived This Week
Motley Fool· 11 months agoA significant miss on quarterly earnings combined with a big change in its C-suite put a damper on CymaBay Therapeutics (NASDAQ: CBAY) stock this week....
Why CymaBay Therapeutics Stock Is Jumping Today
Motley Fool· 8 months agoThe continued momentum is a result of CymaBay's announcement yesterday of positive top-line results from a late-stage clinical study evaluating...
Company News for Feb 13, 2024
Zacks via Yahoo Finance· 2 months agoDiamondback Energy, Inc. (FANG) shares jumped 9.4% after the company made an announcement of its merger agreement with Endeavor Energy Resources valued...
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...
Zacks via Yahoo Finance· 2 months agoFor Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks...
GILD- A Biotech Focused on Boosting Oncology Treatment Reach
MoneyShow via Yahoo Finance· 1 month agoThe EVP of the Kite subsidiary at Gilead Sciences Inc. (GILD) recently presented at the Leerink Partners Global Biopharma Conference. She said the CAR-T industry only has a 15% to 17% share ...
